The effect of insulin-induced hypoglycaemia on cerebral blood flow was examined using the intravenous xenon-clearance technique in 9 patients with Type 1 (insulin-dependent) diabetes (aged 20 to 43 years) and 9 age-matched control subjects before, during and after hypoglycaemia. Cerebral blood flow rose in both groups. The mean basal cerebral flood flow values were not significantly different and during hypoglycaemia mean cerebral blood flow increased by 17% (p = 0.008) in the diabetic patients and by 21% (p = 0.0003) in the control subjects. The results suggest that in young diabetic patients without autonomic neuropathy or microangiopathy cerebral vessels dilate normally in response to hypoglycaemia. The physiological importance of an inc...
OBJECTIVEdTo test the hypothesis that insulin detemir, which is associated with less weight gain tha...
Patients with type 1 diabetes mellitus (T1DM) experience, on average, 2 to 3 hypoglycemic episodes p...
Hypoglycaemia is an acute complication to insulin-treatment in type 1 diabetes mellitus, which affec...
It is unclear whether cerebral blood flow responses to hypoglycemia are altered in people with type ...
During hypoglycaemia, counter-regulatory hormones are released, cognitive function is impaired and c...
The effect of rapid lowering of blood glucose on cerebral blood flow (CBF) was studied in 10 Type 1 ...
The effect of moderate hypoglycemia (p-glucose, 2.0 +/- 0.3 mmol/L; mean +/- SD) on regional cerebra...
Chronic hyperglycaemia and recurrent severe hypoglycaemia have both been implicated as causing cereb...
The thalamus has been found to be activated during the early phase of moderate hypoglycemia. Here, w...
Subclinical systemic microvascular dysfunction exists in asymp-tomatic patients with type 1 diabetes...
Introduction Impaired awareness of hypoglycemia, clinically reflected by the inability to timely det...
The incidence studies on hypoglycemia in Type 1 Diabetes have revealed that the younger the child th...
Objective-To test the hypothesis that insulin detemir, which is associated with less weight gain tha...
OBJECTIVEdTo test the hypothesis that insulin detemir, which is associated with less weight gain tha...
OBJECTIVE—Insulin stimulates brain glucose metabolism, but this effect of insulin is already maximal...
OBJECTIVEdTo test the hypothesis that insulin detemir, which is associated with less weight gain tha...
Patients with type 1 diabetes mellitus (T1DM) experience, on average, 2 to 3 hypoglycemic episodes p...
Hypoglycaemia is an acute complication to insulin-treatment in type 1 diabetes mellitus, which affec...
It is unclear whether cerebral blood flow responses to hypoglycemia are altered in people with type ...
During hypoglycaemia, counter-regulatory hormones are released, cognitive function is impaired and c...
The effect of rapid lowering of blood glucose on cerebral blood flow (CBF) was studied in 10 Type 1 ...
The effect of moderate hypoglycemia (p-glucose, 2.0 +/- 0.3 mmol/L; mean +/- SD) on regional cerebra...
Chronic hyperglycaemia and recurrent severe hypoglycaemia have both been implicated as causing cereb...
The thalamus has been found to be activated during the early phase of moderate hypoglycemia. Here, w...
Subclinical systemic microvascular dysfunction exists in asymp-tomatic patients with type 1 diabetes...
Introduction Impaired awareness of hypoglycemia, clinically reflected by the inability to timely det...
The incidence studies on hypoglycemia in Type 1 Diabetes have revealed that the younger the child th...
Objective-To test the hypothesis that insulin detemir, which is associated with less weight gain tha...
OBJECTIVEdTo test the hypothesis that insulin detemir, which is associated with less weight gain tha...
OBJECTIVE—Insulin stimulates brain glucose metabolism, but this effect of insulin is already maximal...
OBJECTIVEdTo test the hypothesis that insulin detemir, which is associated with less weight gain tha...
Patients with type 1 diabetes mellitus (T1DM) experience, on average, 2 to 3 hypoglycemic episodes p...
Hypoglycaemia is an acute complication to insulin-treatment in type 1 diabetes mellitus, which affec...